BROS Insider Notice: 178,351 Founders Shares Listed for Sale via Morgan Stanley
Rhea-AI Filing Summary
Dutch Bros Inc. (BROS) notice reports a proposed sale under Rule 144 of 178,351 common shares through Morgan Stanley Smith Barney with an aggregate market value of $11,225,411.94. The filing shows these were acquired as founders shares on 09/27/2018 and payment was recorded as N/A at acquisition. The form lists recent related sales dated 05/22/2025 totaling 722,841 shares (159,254 and 563,587) with gross proceeds of $10,641,830.04 and $37,660,574.10, respectively. The issuer has 126,960,284 shares outstanding, making the proposed sale roughly 0.14% of outstanding shares. The signer certifies no undisclosed material adverse information and, if applicable, reliance on a Rule 10b5-1 plan is noted.
Positive
- Full acquisition history provided: the filing specifies acquisition date (09/27/2018) and nature (Founders Shares), supporting traceability.
- Broker and execution details included: Morgan Stanley Smith Barney is named, giving clear execution channel for the proposed sale.
- Certifies no undisclosed material information: signer represents absence of material nonpublic information and notes Rule 10b5-1 reliance procedures.
Negative
- Significant recent insider sales: prior 10b5-1 sales on 05/22/2025 total 722,841 shares with aggregate gross proceeds of about $48.3 million, which may attract investor attention.
- Large dollar value: the proposed sale value ($11.23 million) is material in absolute terms even if small relative to outstanding shares.
Insights
TL;DR: Insider-related sale of founders shares is modest relative to outstanding stock and follows prior 10b5-1 program disposals.
The filing documents a proposed Rule 144 sale of 178,351 shares valued at $11.2 million, acquired as founders shares in 2018. Recent 10b5-1 sales on 05/22/2025 show larger dispositions totaling 722,841 shares for roughly $48.3 million in gross proceeds. Relative to 126.96 million shares outstanding, the current notice represents approximately 0.14% dilution, indicating the sale is unlikely to materially affect market supply alone. Still, clustered sales under 10b5-1 may warrant monitoring for timing and signaling to the market.
TL;DR: Disclosure aligns with Rule 144 requirements and includes representation about material nonpublic information and possible 10b5-1 reliance.
The form provides required acquirer and acquisition details: founders shares dated 09/27/2018 and broker information (Morgan Stanley Smith Barney). It also includes the mandatory certification about no undisclosed material adverse information and references plan adoption/instruction dates when relying on Rule 10b5-1. Documentation appears procedurally complete for a Rule 144 notice, supporting transparency for investor oversight.
FAQ
What does Form 144 filed by BROS report?
When were the shares being sold originally acquired?
How many shares has the filer sold recently for BROS?
What percent of outstanding stock does the proposed sale represent?
Does the filing state whether a 10b5-1 plan is used?